ATE492286T1 - Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität - Google Patents

Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität

Info

Publication number
ATE492286T1
ATE492286T1 AT06711432T AT06711432T ATE492286T1 AT E492286 T1 ATE492286 T1 AT E492286T1 AT 06711432 T AT06711432 T AT 06711432T AT 06711432 T AT06711432 T AT 06711432T AT E492286 T1 ATE492286 T1 AT E492286T1
Authority
AT
Austria
Prior art keywords
immunological
poly
tumor activity
peptide derived
epitope peptide
Prior art date
Application number
AT06711432T
Other languages
English (en)
Inventor
Pierpaolo Correale
Maria Cusi
Guido Francini
Giorgio Giorgi
Original Assignee
Univ Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Siena filed Critical Univ Siena
Application granted granted Critical
Publication of ATE492286T1 publication Critical patent/ATE492286T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/461Cellular immunotherapy characterised by the cell type used
    • A61K39/4611T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/464Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643Vertebrate antigens
    • A61K39/4644Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5154Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06711432T 2005-02-16 2006-02-15 Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität ATE492286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000064A ITRM20050064A1 (it) 2005-02-16 2005-02-16 Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.
PCT/IT2006/000078 WO2006087756A2 (en) 2005-02-16 2006-02-15 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity

Publications (1)

Publication Number Publication Date
ATE492286T1 true ATE492286T1 (de) 2011-01-15

Family

ID=36604211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06711432T ATE492286T1 (de) 2005-02-16 2006-02-15 Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität

Country Status (15)

Country Link
US (1) US8344100B2 (de)
EP (1) EP1848456B1 (de)
JP (1) JP4943348B2 (de)
CN (1) CN101137392A (de)
AT (1) ATE492286T1 (de)
AU (1) AU2006215260B2 (de)
CA (1) CA2598292C (de)
DE (1) DE602006019057D1 (de)
ES (1) ES2357548T3 (de)
IL (1) IL185101A0 (de)
IT (1) ITRM20050064A1 (de)
MX (1) MX2007009896A (de)
NZ (1) NZ560511A (de)
RU (1) RU2007134338A (de)
WO (1) WO2006087756A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20050064A1 (it) 2005-02-16 2006-08-17 Univ Siena Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.
JP5352586B2 (ja) * 2007-07-27 2013-11-27 イマティクス バイオテクノロジーズ ゲーエムベーハー 腫瘍関連ペプチドおよび関連抗癌ワクチンの組成物
US8501242B2 (en) 2009-05-29 2013-08-06 University Of Florida Research Foundation Methods and compositions for treating neoplasia
CN101948508B (zh) * 2010-09-09 2012-07-04 郑州大学 Piwil2抗肿瘤ctl表位肽及其应用
RU2507265C2 (ru) * 2012-05-12 2014-02-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической иммунологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИКИ" СО РАМН) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pCI-UB-POLYEPI, СОДЕРЖАЩАЯ ЭПИТОПЫ ОПУХОЛЬ-АССОЦИИРОВАННЫХ АНТИГЕНОВ ДЛЯ КОЛОРЕКТАЛЬНОГО РАКА, И СПОСОБ ЕЕ ПРИМЕНЕНИЯ ДЛЯ СТИМУЛЯЦИИ СПЕЦИФИЧЕСКОГО ПРОТИВООПУХОЛЕВОГО ИММУННОГО ОТВЕТА ПРОТИВ КЛЕТОК КОЛОРЕКТАЛЬНОГО РАКА
CN113827740A (zh) * 2021-09-17 2021-12-24 青岛农业大学 一种水溶性复合疫苗佐剂的筛选方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US7462354B2 (en) * 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
ITRM20050064A1 (it) 2005-02-16 2006-08-17 Univ Siena Peptide poliepitopico derivato dalla timidilato sintetasi avente attivita' immunologica e antitumorale e composizioni farmaceutiche relative.

Also Published As

Publication number Publication date
US20080305091A1 (en) 2008-12-11
EP1848456B1 (de) 2010-12-22
CN101137392A (zh) 2008-03-05
DE602006019057D1 (de) 2011-02-03
MX2007009896A (es) 2008-02-12
CA2598292C (en) 2017-04-04
US8344100B2 (en) 2013-01-01
AU2006215260A1 (en) 2006-08-24
RU2007134338A (ru) 2009-03-27
EP1848456A2 (de) 2007-10-31
JP4943348B2 (ja) 2012-05-30
WO2006087756A2 (en) 2006-08-24
WO2006087756A3 (en) 2006-11-02
ES2357548T3 (es) 2011-04-27
AU2006215260B2 (en) 2011-04-28
IL185101A0 (en) 2007-12-03
JP2008529522A (ja) 2008-08-07
CA2598292A1 (en) 2006-08-24
NZ560511A (en) 2010-07-30
ITRM20050064A1 (it) 2006-08-17

Similar Documents

Publication Publication Date Title
ZA201001054B (en) Peptide with reduced dimer formation
WO2007067506A3 (en) 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
DK1951730T3 (da) Heteroalkylbundne pyrimidinderivater
WO2007057714A3 (en) Pharmaceutical compositions comprising methotrexate
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
TW200731974A (en) Transdermal system for verenicline
WO2008031556A3 (en) 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
WO2007058942A3 (en) Imidazopyrazines as protein kinase inhibitors
MX2009005011A (es) Imidazopirazinas como inhibidores de proteina quinasa.
PL1910338T3 (pl) Związki heterotetracykliczne jako mimetyki TPO
TW200800967A (en) Benzimidazole thiophene compounds
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
BRPI0606687A2 (pt) composições nutracêuticas
MX2008002166A (es) Compuestos y composiciones como mimeticos de trombopoietina (tpo).
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2007056625A3 (en) Thienopyridine b-raf kinase inhibitors
ATE492286T1 (de) Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität
WO2006133006A3 (en) 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
MY163037A (en) Endoparasiticidal compositions
WO2007087026A3 (en) Solid-state form of amg 706 and pharmaceutical compositions thereof
TW200638932A (en) CCI-779 polymorph and use thereof
WO2007076320A3 (en) Compounds
WO2007071444A3 (en) Esomeprazole arginine
MX2007010361A (es) Sales de fosfato de los compuestos de 6-dimetilaminometil-1(3-meto xifenil)-1, 3-dihidroxi-ciclohexano.
TW200738680A (en) Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties